Imaging end points for monitoring neuroprotection in Parkinson's disease

被引：37

作者：

Brooks, DJ

机构：

[1] Hammersmith Hosp, Imperial Coll, MRC, Ctr Clin Sci,Fac Med, London W12 0NN, England

[2] Hammersmith Hosp, Imperial Coll, Div Neurosci, London W12 0NN, England

来源：

ANNALS OF NEUROLOGY | 2003年 / 53卷

关键词：

D O I：

10.1002/ana.10480

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

In this review, the potential role of positron emission tomography and single-photon emission computed tomography as biological markers for following the progression of Parkinson's disease (PD) is discussed, and their value for assessing the efficacy of putative neuroprotective agents in PD is considered. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective approaches to PD.

引用

页码：S110 / S118

页数：9

共 72 条

[1]

Agid Y., 1987, MOVEMENT DISORD, V2, P166

[2] Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fisher 344 and Sprague-Dawley donors [J].